A minimally invasive approach in the treatment of vesicoureteral reflux in neurogenic bladder in children

Eur Urol. 2009 Jan;55(1):254-6. doi: 10.1016/j.eururo.2008.07.030. Epub 2008 Jul 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Botulinum Toxins, Type A / therapeutic use*
  • Child
  • Combined Modality Therapy
  • Dextrans*
  • Female
  • Humans
  • Hyaluronic Acid*
  • Male
  • Neuromuscular Agents / therapeutic use*
  • Urinary Bladder, Neurogenic / complications*
  • Vesico-Ureteral Reflux / drug therapy*
  • Vesico-Ureteral Reflux / etiology

Substances

  • Dextrans
  • Neuromuscular Agents
  • dextranomer-hyaluronic acid copolymer
  • Hyaluronic Acid
  • Botulinum Toxins, Type A